Modulation of the Acute Inflammatory Response Induced by the Escherichia coli Lipopolysaccharide through the Interaction of Pentoxifylline and Florfenicol in a Rabbit Model.
Victoria CazangaCristina PalmaTomás CasanovaDaniela RojasKarin BarreraCristhian ValenzuelaAracelly AcevedoGabriel AscuiTamara Pérez-JeldresRubén PérezPublished in: Antibiotics (Basel, Switzerland) (2023)
We concluded that the combination of FFC and PTX in our LPS sepsis models demonstrates immunomodulatory effects. An apparent synergistic effect was observed for the IL-1β inhibition, which peaks at three hours and then decreases. At the same time, each drug alone was superior in reducing TNF-α levels, while the combination was inferior. However, the peak of TNF-α in this sepsis model was at 12 h. Therefore, in rabbits plasma IL-1β and TNF-α could be regulated independently, thus, further research is needed to explore the effects of this combination over a more prolonged period.
Keyphrases
- inflammatory response
- rheumatoid arthritis
- escherichia coli
- intensive care unit
- acute kidney injury
- lps induced
- lipopolysaccharide induced
- septic shock
- toll like receptor
- liver failure
- drug induced
- immune response
- anti inflammatory
- staphylococcus aureus
- klebsiella pneumoniae
- adverse drug
- pseudomonas aeruginosa
- computed tomography